1 / 55

Principles of antibiotic therapy in paediatrics

Principles of antibiotic therapy in paediatrics. Dr. György Fekete. Antibiotics 1. What is the reason? Indication? - local infection - empiric and targeted teatment - fever + general symptoms (CRP, WBC count and smear, etc.). 2. Previous microbiological investigations?

ursula-ball
Download Presentation

Principles of antibiotic therapy in paediatrics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Principles of antibiotic therapy in paediatrics Dr. György Fekete

  2. Antibiotics 1. What is the reason? Indication? - local infection - empiric and targeted teatment - fever + general symptoms (CRP, WBC count and smear, etc.)

  3. 2. Previous microbiological investigations? - throat - urine - haemoculture - cerebrospinal fluid

  4. 3. What is the potential (bacterial) cause of infection? - age (newborn, infant, toddler…) - medical procedure, hospitalisation - immune deficiency - organ damage (spleen, liver, kidney)

  5. Neonatal sepsis /meningitis • Focal infection: pneumonia, RDS • Group B streptococci, E. coli, other Gram-negative rods, Listeria monocytogenes • Th: Ampicillin+ gentamicin • third generation cephalosporin instead of aminoglycoside

  6. Bacterial meningitis in children, 2months to 12 yrs • S. pneumoniae, N. meningitidis, (H. influenzae type b) Therapy: - cefotaxime / ceftriaxone + vancomycine - 3. generation cephalosporines (Cefotaxime, Ceftriaxone)

  7. 4. Which antibiotic will be optimal? First choice? - data of bacterial resistance - site of infection – penetration? - side effects? - bactericide effect - administration: 1x / day - not expensive

  8. 5. Any combination is appropriate? - nosocomial infection - sepsis - abdominal and pelvic infections - endocarditis - empiric treatment - active tuberculosis

  9. Active tuberculosis • Treatment: INH, rifampin, pyrazinamide • Ethambutol, ethionamide

  10. 6. Metabolism, excretion? - kidney, liver (monitoring) - renal: aminoglycosides - liver:erythromycin, clindomycin 7. Mode of administration - iv, oral - „switch”

  11. 8. Dosage ? 9. Changing of antiobiotic drug? Indications? 10. How long should we treat? - Preterm and newborn babies need antibiotic therapy of longer duration (sepsis, bacterial meningitis, etc.)

  12. Antimicrobial prophylaxis Neonatal conjunctivitis • Chlamydia trachomatis • 0,5% erythromycin topically • Neisseria gonorrhoeae • 1% silver nitrate or • 0,5% erythromycin topically

  13. Antimicrobial prophylaxis • Splenectomy / asplenia • Str. pneumoniae • Penicillin

  14. Resistant clones of microorganisms • Str. pneumoniae • Staph. aureus • Virulent • Serious infections • Overuse of antibiotics • Viral infections • Broad spectrum antimicrobial agents

  15. Antibiotic management of Staphylococcus aureus infections in US Children’s hospitals, 1999-2008 • Trends in antibiotic management for S. aureus infections, hospitalized children • The use of vancomycin, clindamycin, linezolid, trimethoprim-sulfamethoxazole, cefazolin, and oxacillin/nafcillin were examined for percentage use and days of therapy per 1000 patient- day • 64 813 patients had a discharge diagnosis for S. aureus infection • The incidence of methicillin-resistant S. aureus (MRSA) infections increased 10-fold (2 to 21 cases per 1000 admissions), methicillin- susceptible infection rate remained stable • Clindamycin showed the greatest increase: 21% in 1999 and 63% in 2008 • Importance of continuous monitoring of local S. aureus susceptibility patterns Herigon J.C et al. Pediatrics 2010, 125:1267

  16. Broad - spectrum antimicrobial agents • Drastic changes in bowel flora • Bleeding disorders • Emergence of resistant organisms • Superinfections: yeasts, enterococci

  17. Local (hospital) microbiological laboratory • Knowing the prevalence of antibiotic – resistant organisms in a particular community (nursery) is helpful in choosing the first-line antibiotic regimens

  18. Specific therapeutic values • Vancomycin: methicillin-resistant staphylococci • Metronidazole: anaerobic infections • Ceftazidine: Pseudomonas aeruginosa • Trimethoprime+ sulfamethoxazole: shigellosis, salmonellosis, Pneumocysis carinii ( pentamidine)

  19. Test of efficacy= patient’s response • No respond to seemingly appropriate therapy: reassessment is needed! • In some infections additional supportive treatment ( surgical) is necessary

  20. Tonsillitis, tonsillopharyngitis • Streptococcus pyogenes : Penicillin for 10 days • Penicillin allergy: macrolid antibiotics • Non- Streptococcus origin: amoxicillin, amoxicillin+ clavulanic acid, macrolids, cephalosporin antibiotics

  21. Anaerobic infections • Oropharynx, gastrointestinal tract, vagina, skin • Gram- negative nonsporulating rods: Bacteroides, Fusobacterium • Gram-positive nosporulating rods: Eubacterium, Propionibacterium

  22. Anaerobic infections • Neonates: prolonged rupture of membranes, amnionitis, obstetric difficulties • Peritonitis, appendicitis • Aspiration pneumonia with lung abscess • Orofacial infections • Brain abscess

  23. Periodontal infection („trench mouth”)Acute Necrotizing Ulcerative Gingivitis ( ANUG) • Periapical abscesses • Anaerobic osteomyelitis of the mandible /maxilla

  24. Vincent stomatitits • Ulcers covered by brown/grey, foul-smelling exudate

  25. Ludwig angina • Acute cellulitis of the sublingual and submandibular spaces • Rapid spread • Edema of the tongue and airway

  26. Anaerobic infections/ treatment • Cefoxitin, amoxicillin/ clavulanate, clindamycin • Metronidazole • Cefotetan • Imipenem, merapenem • Piperacillin, tazobactam

  27. CEPHALOSPORIN ANTIBIOTICS 1. generation drugs Cefazolin (Kefzol) does not cross the blood- brain barrier. No use for initial th. of sepsis / meningitis Cefalexin (Keflex. Ospexin) Cefadoxil (Duracef)

  28. 2. generation drugs Cefamandol (Mandokef) Cefuroxim (Zinnat, Zinacef) Cefoxitin (Mefoxin) Cefaclor (Ceclor)

  29. 3. generation drugs Cefotaxim e (Claforan) Ceftriaxone (Rocephin) Cefoperazon (Cefobid) Ceftazidim ((Fortum) Cefixim (Suprax) Ceftibuten (Cedax)

  30. 4. generation drug Cefepim (Maxipime)

  31. Presentation • 7-year-old boy • 3 weeks of headache refractory to acetaminophen, 1 day of altered mental status, diplopia, photophobia • Physical examination: he is difficult to arouse and is confused. He vomits once in the ED. • No skin lesions, signs of meningeal irritation, or joint swelling. Bilateral papilledema and photophobia • WBC 15.8x109/L, 85% segmented neutrophils. Lumbar puncture, CSF sent for Lyme titers, serum antibodies: positive for IgG and negative for IgM • Th: 28 days IV ceftriaxone (100 mg/kg per day) • Additional questioning:2 months prior he had erythema migrans, was diagnosed as having Lyme disease, and was treated with 21 days of cefuroxime

  32. PENICILLIN Penicillin G V Streptococcus procain-penicillin Str. pneumoniae

  33. METHICILLIN Oxacillin Staphylococcus aureus Nafcillin

  34. AMINOPENICILLIN (ampicillin , amoxicillin) Streptococcus B Str. pneumoniae Listeria

  35. AMINOPENICILLIN beta+-lactamase respiratory , inhibitor urinary tract infections (ampicillin+sulfactam, amoxicillin+clavulanic acid)

  36. UREIDOPENICILLIN mezlocillin, piperacillin (+beta-lactamase inhibitor as well) piperacillin/tazobactam Severe systemic infections

  37. Tetracyclines • Good effect: • Chlamydia, Mycoplasma, Actinomyces, Lyme disease, pelvic infections, urethritis, brucellosis • Contraindicated before the age of 10 yrs!

  38. ANTIBIOTIC DRUGS Active ingredientProduct Amoxicillin Aktil, Augmentin + clavulanic acid Ampicillin Ospamox, Penstabil, Pentrexyl

  39. Active ingredientProduct Ampicillin Unasyn +Sulbactam Azithromycin Sumamed Azlocillin Securopen

  40. Active ingredientProduct Cefadroxil Duracef Ceftazidime Fortum Ceftriaxon Rocephin Cefixim Suprax

More Related